MANGALAM ORGANICS Latest Share Price (MANORG)
TODAY IN ONE LINE
MANORG edged up 0.8% on above-average volume (349572.6x avg), in line with Nifty's 1.3% move, supported by recent strong earnings.
With a market cap of ₹371.87 Cr., it trades at a P/E of 17.88. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
MANGALAM ORGANICS flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 229.1% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 16.6% and Profit up 21.5%
- ●Reasonable ValuationTrading at a moderate P/E of 18.8x
- ●High Promoter HoldingPromoters hold 58.6% skin-in-the-game
- ●Promoter BuyingPromoters increased holdings by 58.65% QoQ
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Price MomentumStock underperformed, dropping 28.8% over 1Y
- ●Poor Capital ReturnsLow ROE of 4.5%
- ●Rising Receivables vs SalesReceivables grew 21.7% outpacing sales growth of 7.4%
Latest MANGALAM ORGANICS News
What changed recently?
Recent events, corporate actions, and announcements.
MANGALAM ORGANICS valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for MANGALAM ORGANICS, framed against the sector median so the premium or discount is obvious at a glance.
MANGALAM ORGANICS trades at a P/E of 17.88× and P/B of 1.17×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
MANGALAM ORGANICS technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for MANGALAM ORGANICS — derived from the latest tape, not yesterday's close.
MANGALAM ORGANICS last traded at ₹430.7 with an intraday range of ₹423.45–₹435 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹430.70| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 459.08 | +28.38 | +6.59% |
| R3 | 447.53 | +16.83 | +3.91% |
| R2 | 441.27 | +10.57 | +2.45% |
| R1 | 435.98 | +5.28 | +1.23% |
| PIVOT | 429.72 | -0.98 | -0.23% |
| CURRENT | 430.70 | — | — |
| S1 | 424.43 | -6.27 | -1.45% |
| S2 | 418.17 | -12.53 | -2.91% |
| S3 | 412.88 | -17.82 | -4.14% |
| S4 | 401.33 | -29.37 | -6.82% |
MANORG is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹423.45–₹433.5
Trading Inside opening range
MANGALAM ORGANICS financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for MANGALAM ORGANICS — consolidated or standalone — with margins, YoY growth and key ratios inline.
MANGALAM ORGANICS reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹371.87 Cr. and reported EPS of ₹8.49.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 623 | 623 ▲ 0.0% |
| Sales Growth YoY %Derived | 17.46% | — |
| Other Income | 5 | 5 ▲ 0.0% |
| Total Income | 627 | 627 ▲ 0.0% |
| 328 | 328 ▲ 0.0% | |
| Gross ProfitDerived | 295 | 295 ▲ 0.0% |
| Gross Margin %Derived | 47.31% | 47.31% |
| 207 | 207 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 88 | 88 ▲ 0.0% |
| OPM %Derived | 14.11% | 14.11% |
| 52 | 52 ▲ 0.0% | |
| Profit Before Tax (PBT) | 33 | 33 ▲ 0.0% |
| 8 | 8 ▲ 0.0% | |
| Effective Tax %Derived | 22.65% | 22.65% |
| Total Profit for Period | 26 | 26 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | 26 | 26 ▲ 0.0% |
| Net Profit Margin %Derived | 4.14% | 4.14% |
| PAT Growth YoY %Derived | 104.46% | — |
| Earnings Per Share (EPS ₹) | 30.07 | 30.07 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 594 | 594 ▲ 0.0% |
| Material Cost % of RevenueDerived | 58.68% | 58.68% |
| Employee Cost % of RevenueDerived | 8.02% | 8.02% |
| Other Cost % of RevenueDerived | 25.19% | 25.19% |
| Interest Coverage (x)Derived | 2.14x | 2.14x |
| Period | Mar 2021 | Mar 2022 | May 2022 | Mar 2023 | May 2023 | Mar 2024 | May 2024 | Mar 2025 | Mar 2026 | May 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 338 | 491 ▲ 45.1% | 491 ▲ 0.0% | 493 ▲ 0.4% | 493 ▲ 0.0% | 494 ▲ 0.2% | 494 ▲ 0.0% | 530 ▲ 7.4% | 623 ▲ 17.5% | 623 ▲ 0.0% | |
| Sales Growth YoY %Derived | — | 45.06% | — | 0.38% | 0.38% | 0.20% | 0.20% | 7.39% | 17.46% | — | |
| Other Income | 1 | 1 ▲ 37.5% | 1 ▲ 0.0% | 0 ▼ 76.6% | 0 ▲ 0.0% | 1 ▲ 130.4% | 1 ▲ 0.0% | 0 ▼ 57.0% | 5 ▲ 1321.4% | 5 ▲ 0.0% | |
| Total Income | 339 | 492 ▲ 45.0% | 492 ▲ 0.0% | 493 ▲ 0.2% | 493 ▲ 0.0% | 494 ▲ 0.3% | 494 ▲ 0.0% | 530 ▲ 7.3% | 627 ▲ 18.3% | 627 ▲ 0.0% | |
123 | 277 ▲ 124.5% | 277 ▲ 0.0% | 343 ▲ 23.9% | 343 ▲ 0.0% | 303 ▼ 11.8% | 303 ▲ 0.0% | 273 ▼ 9.6% | 328 ▲ 19.9% | 328 ▲ 0.0% | ||
| Gross ProfitDerived | 215 | 214 ▼ 0.6% | 214 ▲ 0.0% | 149 ▼ 30.1% | 149 ▲ 0.0% | 191 ▲ 27.8% | 191 ▲ 0.0% | 257 ▲ 34.4% | 295 ▲ 14.8% | 295 ▲ 0.0% | |
| Gross Margin %Derived | 63.53% | 43.55% | 43.55% | 30.31% | 30.31% | 38.67% | 38.67% | 48.40% | 47.31% | 47.31% | |
87 | 123 ▲ 40.9% | 123 ▲ 0.0% | 152 ▲ 23.9% | 152 ▲ 0.0% | 152 ▲ 0.1% | 152 ▲ 0.0% | 198 ▲ 30.1% | 207 ▲ 4.4% | 207 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 128 | 91 ▼ 28.8% | 91 ▲ 0.0% | -3 ▼ 103.0% | -3 ▲ 0.0% | 39 ▲ 1498.8% | 39 ▲ 0.0% | 59 ▲ 51.5% | 88 ▲ 49.9% | 88 ▲ 0.0% | |
| OPM %Derived | 37.78% | 18.54% | 18.54% | -0.56% | -0.56% | 7.83% | 7.83% | 11.05% | 14.11% | 14.11% | |
15 | 19 ▲ 32.2% | 19 ▲ 0.0% | 31 ▲ 63.0% | 31 ▲ 0.0% | 35 ▲ 13.2% | 35 ▲ 0.0% | 42 ▲ 19.3% | 52 ▲ 23.6% | 52 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 114 | 73 ▼ 36.0% | 73 ▲ 0.0% | -34 ▼ 146.1% | -34 ▲ 0.0% | 4 ▲ 111.8% | 4 ▲ 0.0% | 17 ▲ 316.9% | 33 ▲ 100.4% | 33 ▲ 0.0% | |
29 | 19 ▼ 33.8% | 19 ▲ 0.0% | -7 ▼ 133.6% | -7 ▲ 0.0% | 1 ▲ 116.9% | 1 ▲ 0.0% | 4 ▲ 264.7% | 8 ▲ 87.5% | 8 ▲ 0.0% | ||
| Effective Tax %Derived | 25.74% | 26.59% | 26.59% | 19.36% | 19.36% | 27.67% | 27.67% | 24.20% | 22.65% | 22.65% | |
| Total Profit for Period | 85 | 54 ▼ 36.7% | 54 ▲ 0.0% | -27 ▼ 150.7% | -27 ▲ 0.0% | 4 ▲ 115.7% | 4 ▲ 0.0% | 13 ▲ 193.9% | 26 ▲ 104.5% | 26 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | 85 | 54 ▼ 36.7% | 54 ▲ 0.0% | -27 ▼ 150.7% | -27 ▲ 0.0% | 4 ▲ 115.7% | 4 ▲ 0.0% | 13 ▲ 193.9% | 26 ▲ 104.5% | 26 ▲ 0.0% | |
| Net Profit Margin %Derived | 25.09% | 10.95% | 10.95% | -5.53% | -5.53% | 0.87% | 0.87% | 2.38% | 4.14% | 4.14% | |
| PAT Growth YoY %Derived | — | -36.68% | — | -150.66% | -150.66% | 115.74% | 115.74% | 193.90% | 104.46% | — | |
| Earnings Per Share (EPS ₹) | 99.11 | 62.75 ▼ 36.7% | 62.75 ▲ 0.0% | -31.79 ▼ 150.7% | -31.79 ▲ 0.0% | 5.00 ▲ 115.7% | 5.00 ▲ 0.0% | 14.71 ▲ 194.2% | 30.07 ▲ 104.4% | 30.07 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▲ 74.9% | -0 ▲ 0.0% | 0 ▲ 312.8% | 0 ▲ 0.0% | -0 ▼ 153.0% | -0 ▲ 0.0% | -0 ▼ 33.6% | -0 ▼ 300.5% | -0 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 225 | 419 ▲ 86.2% | 419 ▲ 0.0% | 527 ▲ 25.7% | 527 ▲ 0.0% | 490 ▼ 6.9% | 490 ▲ 0.0% | 514 ▲ 4.8% | 594 ▲ 15.6% | 594 ▲ 0.0% | |
| Material Cost % of RevenueDerived | 43.50% | 57.95% | 57.95% | 83.12% | 83.12% | 52.47% | 52.47% | 58.96% | 58.68% | 58.68% | |
| Employee Cost % of RevenueDerived | 7.96% | 6.06% | 6.06% | 7.04% | 7.04% | 7.92% | 7.92% | 7.84% | 8.02% | 8.02% | |
| Other Cost % of RevenueDerived | 17.79% | 18.95% | 18.95% | 23.83% | 23.83% | 22.92% | 22.92% | 29.51% | 25.19% | 25.19% | |
| Interest Coverage (x)Derived | 114.05x | 18.10x | 18.10x | -1.47x | -1.47x | 1.21x | 1.21x | 1.76x | 2.14x | 2.14x |
MANGALAM ORGANICS segment analysis : revenue and profit mix.
Disclosed business segments at MANGALAM ORGANICS with their share of revenue and profit, switchable between consolidated and standalone reporting.
MANGALAM ORGANICS discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for MANGALAM ORGANICS.
Our AI distills the core fundamental drivers supporting MANGALAM ORGANICS, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
MANGALAM ORGANICS's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Valuation risk. a P/E above 23 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.44. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
MANGALAM ORGANICS peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — MANGALAM ORGANICS is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
MANGALAM ORGANICS chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for MANGALAM ORGANICS — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
MANGALAM ORGANICS delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for MANGALAM ORGANICS over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in MANGALAM ORGANICS stood at 77.4% of traded volume, against a 20-day average of 73.7%.
MANGALAM ORGANICS announcements: results, concalls, ratings, M&A.
Filings MANGALAM ORGANICS sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
MANGALAM ORGANICS files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 87 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Mangalam Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
General Updates
Mangalam Organics Limited has informed the Exchange about General Updates about the appointment of the Statutory Auditors of the Company for a period…
Shareholders meeting
Mangalam Organics Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026. Further, the…
Shareholders meeting
Mangalam Organics Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2026
Demise
Mangalam Organics Limited has informed the Exchange regarding Demise of Mr Sidharath Singh Sekhon, Non- Executive Independent Director of the company…
Investor decks & rating reports.
General Updates
General Updates
Updates
Updates
Updates
MANGALAM ORGANICS dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue MANGALAM ORGANICS has declared, sequenced by announce and record date.
MANGALAM ORGANICS corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About MANGALAM ORGANICS: business, sector, key facts.
What MANGALAM ORGANICS does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
MANGALAM ORGANICS operates in the Commodity Chemicals industry under the Chemicals sector, listed as NSE: MANORG, BSE: 514418.
Mangalam Organics Limited (MANORG) is a prominent Indian chemical manufacturer with a global reach. Their core business revolves around the production and sale of a diverse range of chemical products, primarily categorized into terpene and resin products. This specialization positions them within various industrial sectors, highlighting their versatility as a chemical supplier.
The company's terpene product line is extensive, encompassing key components like camphor (in various forms including tablets and oil), camphene, isobornyl acetate, Isoborneol, dipentene, and terpineol. These are widely used across numerous industries, ranging from household applications and religious ceremonies to healthcare, hygiene, and industrial processes such as textile dyeing, paint manufacturing, and cleaning solutions. The inclusion of sodium acetate trihydrate and pine tar further broadens their offerings within this category.
In addition to terpenes, MANORG manufactures a variety of resin products. These include terpene phenolic and alkyl phenolic resins, along with penta and glycerol modified ester gums. These resins find applications in a similarly diverse range of industries, including adhesives, tires, rubber, chewing gums, and printing inks. This demonstrates a strategic approach to supplying essential chemical components across multiple industrial value chains.
The company's history dates back to 1981, initially operating under the name Dujodwala Products Limited. A name change to Mangalam Organics Limited occurred in October 2013, reflecting potential shifts in branding or strategic focus. Currently headquartered in Mumbai, India, MANORG leverages its established presence to serve both domestic and international markets, indicating a successful track record in chemical manufacturing and distribution.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AMINES & PLASTICIZERS (AMNPLST) Share PricePeer
- ANDHRA SUGARS (ANDHRSUGAR) Share PricePeer
- CHEMFAB ALKALIS (CHEMFAB) Share PricePeer
- CHEMPLAST SANMAR (CHEMPLASTS) Share PricePeer
- DEEPAK FERTILIZERS & PETR (DEEPAKFERT) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about MANGALAM ORGANICS (MANORG).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of MANGALAM ORGANICS (MANORG)?
The current share price of MANGALAM ORGANICS (MANORG) is ₹430.70. Today, the stock has gained by ₹3.45 (0.81%), trading in a range of ₹423.45 to ₹435.00. The stock opened at ₹432.00 with a trading volume of 4,090 shares.
02Is MANGALAM ORGANICS stock a good investment for long-term?
MANGALAM ORGANICS can be considered for long-term investment based on several factors. The company has a market capitalization of ₹371.87 Cr., P/E ratio of 17.88, ROE of 4.52%, and ROCE of 5.12%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of MANGALAM ORGANICS stock?
The 52-week high price of MANGALAM ORGANICS (MANORG) is ₹635.00, while the 52-week low is ₹356.25. Currently trading at ₹430.70, the stock is 20.9% above its 52-week low and 32.17% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy MANGALAM ORGANICS stock at the current price?
Whether to buy MANGALAM ORGANICS stock at ₹430.70 depends on multiple factors. The stock is currently trading with a P/E ratio of 17.88 and P/B ratio of 1.17. Today's performance shows a gain of 0.81%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of MANGALAM ORGANICS and when is the next dividend?
MANGALAM ORGANICS offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹430.70, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of MANGALAM ORGANICS?
MANGALAM ORGANICS's key financial metrics include: P/E Ratio: 17.88, P/B Ratio: 1.17, ROE: 4.52%, ROCE: 5.12%, Dividend Yield: 0%, EPS: ₹8.49, Book Value: ₹372.00, and Debt-to-Equity: 0.94. The company's market cap stands at ₹371.87 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is MANGALAM ORGANICS stock performing today in the market?
MANGALAM ORGANICS stock opened at ₹432.00 and is currently trading at ₹430.70, showing a gain of ₹3.45 (0.81%). The intraday high is ₹435.00 and low is ₹423.45. The trading volume stands at 4,090 shares, indicating moderate market participation today.
08What is the P/E ratio of MANGALAM ORGANICS and what does it indicate?
MANGALAM ORGANICS has a Price-to-Earnings (P/E) ratio of 17.88, which means investors are willing to pay 17.88 for every ₹1 of earnings. With an EPS of ₹8.49, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about MANGALAM ORGANICS (MANORG) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.